Logo image of TOT

Totalenergies Se ADR (TOT) Stock Fundamental Analysis

NYSE:TOT - New York Stock Exchange, Inc. -

48.3  -0.29 (-0.6%)

After market: 48.3 0 (0%)

Fundamental Rating

2

Taking everything into account, TOT scores 2 out of 10 in our fundamental rating. TOT was compared to 214 industry peers in the Oil, Gas & Consumable Fuels industry. TOT may be in some trouble as it scores bad on both profitability and health. TOT has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

TOT had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -1.46%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -0.81%
PM (TTM) -3.28%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

There is no outstanding debt for TOT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

TOT has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 1.19 indicates that TOT should not have too much problems paying its short term obligations.
TOT has a Quick Ratio of 1.19. This is a bad value and indicates that TOT is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 0.96

3

3. Growth

3.1 Past

The earnings per share for TOT have decreased strongly by -53.14% in the last year.
TOT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -20.25% yearly.
Looking at the last year, TOT shows a very negative growth in Revenue. The Revenue has decreased by -29.43% in the last year.
Measured over the past years, TOT shows a decrease in Revenue. The Revenue has been decreasing by -3.55% on average per year.
EPS 1Y (TTM)-53.14%
EPS 3Y-29.27%
EPS 5Y-20.25%
EPS Q2Q%66.67%
Revenue 1Y (TTM)-29.43%
Revenue growth 3Y-7.06%
Revenue growth 5Y-3.55%
Sales Q2Q%0.15%

3.2 Future

TOT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.34% yearly.
TOT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.43% yearly.
EPS Next Y215.32%
EPS Next 2Y84.81%
EPS Next 3Y50.76%
EPS Next 5Y29.34%
Revenue Next Year27.21%
Revenue Next 2Y13.08%
Revenue Next 3Y5.56%
Revenue Next 5Y1.43%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TOT Yearly Revenue VS EstimatesTOT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B 200B
TOT Yearly EPS VS EstimatesTOT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 25.45, TOT can be considered very expensive at the moment.
When comparing the Price/Earnings ratio of TOT to the average of the S&P500 Index (24.85), we can say TOT is valued inline with the index average.
The Price/Forward Earnings ratio is 9.70, which indicates a very decent valuation of TOT.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.89, TOT is valued rather cheaply.
Industry RankSector Rank
PE 25.45
Fwd PE 9.7
TOT Price Earnings VS Forward Price EarningsTOT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.69
TOT Per share dataTOT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

TOT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as TOT's earnings are expected to grow with 50.76% in the coming years.
PEG (NY)0.12
PEG (5Y)N/A
EPS Next 2Y84.81%
EPS Next 3Y50.76%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.80%, TOT is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.40, TOT pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.8%

5.2 History

The dividend of TOT decreases each year by -5.54%.
TOT has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-5.54%
Div Incr YearsN/A
Div Non Decr YearsN/A
TOT Yearly Dividends per shareTOT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 1 2 3

5.3 Sustainability

TOT has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-175.38%
EPS Next 2Y84.81%
EPS Next 3Y50.76%

Totalenergies Se ADR

NYSE:TOT (6/10/2021, 8:04:00 PM)

After market: 48.3 0 (0%)

48.3

-0.29 (-0.6%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners5.92%
Inst Owner Change1.8%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap128.15B
Analysts81.8
Price Target59.54 (23.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.8%
Yearly Dividend2.32
Dividend Growth(5Y)-5.54%
DP-175.38%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 25.45
Fwd PE 9.7
P/S 1.07
P/FCF N/A
P/OCF N/A
P/B 1.15
P/tB N/A
EV/EBITDA 7.69
EPS(TTM)1.9
EY3.93%
EPS(NY)4.98
Fwd EY10.31%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS45.14
BVpS42.1
TBVpSN/A
PEG (NY)0.12
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.46%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -0.81%
PM (TTM) -3.28%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 0.96
Altman-Z N/A
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53.14%
EPS 3Y-29.27%
EPS 5Y-20.25%
EPS Q2Q%66.67%
EPS Next Y215.32%
EPS Next 2Y84.81%
EPS Next 3Y50.76%
EPS Next 5Y29.34%
Revenue 1Y (TTM)-29.43%
Revenue growth 3Y-7.06%
Revenue growth 5Y-3.55%
Sales Q2Q%0.15%
Revenue Next Year27.21%
Revenue Next 2Y13.08%
Revenue Next 3Y5.56%
Revenue Next 5Y1.43%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A